Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2021-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.732903/full |
| _version_ | 1818624311277125632 |
|---|---|
| author | Daniel A. Ladin Eman Soliman Eman Soliman LaToya Griffin Rukiyah Van Dross Rukiyah Van Dross |
| author_facet | Daniel A. Ladin Eman Soliman Eman Soliman LaToya Griffin Rukiyah Van Dross Rukiyah Van Dross |
| author_sort | Daniel A. Ladin |
| collection | DOAJ |
| first_indexed | 2024-12-16T18:54:56Z |
| format | Article |
| id | doaj.art-3a2aeaef3df24e2ab385f29005ffa6a3 |
| institution | Directory Open Access Journal |
| issn | 1663-9812 |
| language | English |
| last_indexed | 2024-12-16T18:54:56Z |
| publishDate | 2021-07-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj.art-3a2aeaef3df24e2ab385f29005ffa6a32022-12-21T22:20:34ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-07-011210.3389/fphar.2021.732903732903Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer AgentsDaniel A. Ladin0Eman Soliman1Eman Soliman2LaToya Griffin3Rukiyah Van Dross4Rukiyah Van Dross5Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC, United StatesDepartment of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC, United StatesDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig, EgyptDepartment of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC, United StatesDepartment of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC, United StatesCenter for Health Disparities, East Carolina University, Greenville, NC, United Stateshttps://www.frontiersin.org/articles/10.3389/fphar.2021.732903/fullcannabinoidscancerin vivoclinical studiesclinical trialstherapeutics |
| spellingShingle | Daniel A. Ladin Eman Soliman Eman Soliman LaToya Griffin Rukiyah Van Dross Rukiyah Van Dross Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents Frontiers in Pharmacology cannabinoids cancer in vivo clinical studies clinical trials therapeutics |
| title | Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents |
| title_full | Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents |
| title_fullStr | Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents |
| title_full_unstemmed | Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents |
| title_short | Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents |
| title_sort | corrigendum preclinical and clinical assessment of cannabinoids as anti cancer agents |
| topic | cannabinoids cancer in vivo clinical studies clinical trials therapeutics |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2021.732903/full |
| work_keys_str_mv | AT danielaladin corrigendumpreclinicalandclinicalassessmentofcannabinoidsasanticanceragents AT emansoliman corrigendumpreclinicalandclinicalassessmentofcannabinoidsasanticanceragents AT emansoliman corrigendumpreclinicalandclinicalassessmentofcannabinoidsasanticanceragents AT latoyagriffin corrigendumpreclinicalandclinicalassessmentofcannabinoidsasanticanceragents AT rukiyahvandross corrigendumpreclinicalandclinicalassessmentofcannabinoidsasanticanceragents AT rukiyahvandross corrigendumpreclinicalandclinicalassessmentofcannabinoidsasanticanceragents |